Skin News and Research

RSS

Study opens door towards personalized medicine for children with eczema

Atopic dermatitis, or eczema, is a common skin disorder that usually starts by 5 years of age, but virtually all of the studies that have defined the immune changes underlying eczema and are directing new treatment options have been done in adult skin.

5 Oct 2016

Two Zika vaccine candidates protect newborn mice against neurological damage

Two vaccines against Zika virus developed at the University of Pittsburgh School of Medicine have successfully conveyed immunity from female mice to pups conceived weeks after the mother's vaccination.

4 Oct 2016

Color-changing wearable sensor can inform users of total UV exposure

According to the American Cancer Society approximately 5.4 million basal and squamous cell skin cancers are diagnosed each year.

4 Oct 2016

UEF research shows retinal changes may be detected earlier than brain changes

Diseases of the central nervous system (CNS) may manifest as pathological changes in the retina of the eye.

3 Oct 2016

Household dust exposes people to potentially harmful chemicals, study finds

Household dust exposes people to a wide range of toxic chemicals from everyday products, according to a study led by researchers at Milken Institute School of Public Health at the George Washington University.

3 Oct 2016

New portable adhesive patch drives small electrical current to promote wound healing

Good news for the millions of people who suffer from skin wounds that won't heal. A team of researchers at The Ohio State University has brought a potentially transformative solution to the problem by creating a portable adhesive patch that drives a continuous, small electrical current to stimulate healing and reduce the risk of infection.

30 Sep 2016

FDA recommends consumers to stop using homeopathic teething tablets and gels

The U.S. Food and Drug Administration is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA recommends that consumers stop using these products and dispose of any in their possession.

30 Sep 2016

DHA intake can prevent known trigger of lupus, study finds

A team of Michigan State University researchers has found that consuming an omega-3 fatty acid called DHA, or docosahexaenoic acid, can stop a known trigger of lupus and potentially other autoimmune disorders.

30 Sep 2016

FDA approves automated insulin delivery device for type 1 diabetes

The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.

29 Sep 2016

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

28 Sep 2016

Biomedical engineers develop artificial blood vessels capable of growth within recipient

In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient.

27 Sep 2016

Psychological support may be crucial for physical recovery of breast cancer patients

The words no one wants to hear: "You have breast cancer." Unfortunately, close to 300,000 American women are expected to receive that diagnosis each year.

27 Sep 2016

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.

27 Sep 2016

Scientists discover trypanosomes hiding in the skin of individuals with no symptoms

Scientists from the Trypanosome Cell Biology Unit (Institut Pasteur/Inserm), working in collaboration with scientists from the University of Glasgow, have demonstrated the presence of a large quantity of trypanosomes – the parasites responsible for sleeping sickness – in the skin of individuals with no symptoms.

27 Sep 2016

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Osteoarthritis is a debilitating condition that affects at least 27 million people in the United States, and at least 12 percent of osteoarthritis cases stem from earlier injuries.

27 Sep 2016

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

The Endocrine Society today issued a Clinical Practice Guideline recommending continuous glucose monitors (CGMs) as the gold standard of care for adults with Type 1 diabetes.

26 Sep 2016

AlloSource to share early results of ProChondrix Cartilage Restoration Matrix at ICRS Congress

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix Cartilage Restoration Matrix during the International Cartilage Repair Society's 13th World Congress in Sorrento-Naples, Italy.

26 Sep 2016

Allergan wins FDA approval to market new NATRELLE INSPIRA Cohesive breast implants

Allergan plc today announced the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision surgery a new breast shaping option that combines a high gel fill ratio and Allergan's highly cohesive gel1, for a customized result.

24 Sep 2016

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

24 Sep 2016

British Lung Foundation announces funding for IPF research

Britons are officially three times more likely to die of the incurable lung condition idiopathic pulmonary fibrosis (IPF), than in a road accident. Despite this, the disease is so unheard of and underfunded in research doctors still don’t know what causes it.

From Asthma + Lung UK 24 Sep 2016

Skin News and Research

Study opens door towards personalized medicine for children with eczema

Two Zika vaccine candidates protect newborn mice against neurological damage

Color-changing wearable sensor can inform users of total UV exposure

UEF research shows retinal changes may be detected earlier than brain changes

Household dust exposes people to potentially harmful chemicals, study finds

New portable adhesive patch drives small electrical current to promote wound healing

FDA recommends consumers to stop using homeopathic teething tablets and gels

DHA intake can prevent known trigger of lupus, study finds

FDA approves automated insulin delivery device for type 1 diabetes

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

Biomedical engineers develop artificial blood vessels capable of growth within recipient

Psychological support may be crucial for physical recovery of breast cancer patients

Combination of different drugs could improve effect of immunotherapy on skin cancer

Scientists discover trypanosomes hiding in the skin of individuals with no symptoms

Nanoparticle injections may help prevent cartilage degeneration in osteoarthritis patients

Endocrine Society Clinical Practice Guideline recommends CGMs for Type 1 diabetes patients

AlloSource to share early results of ProChondrix Cartilage Restoration Matrix at ICRS Congress

Allergan wins FDA approval to market new NATRELLE INSPIRA Cohesive breast implants

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

British Lung Foundation announces funding for IPF research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News